#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma refractory Choroid melanoma Iron overload Biliary cancer metastatic Medulloblastoma Marginal zone lymphoma Cutaneous T-cell lymphoma Interstitial lung disease Red blood cell abnormality Retinopathy proliferative Pyoderma gangrenosum Waldenstrom's macroglobulinaemia Cutaneous calcification NTRK gene fusion overexpression Arterial disorder More trials…

    Learn about Rare Diseases

    Netherton’s syndrome – Treatment Ewing’s sarcoma Bronchopulmonary dysplasia – Life with Disease Mitochondrial myopathy – Trials in Disease Skin angiosarcoma – Life with Disease Fabry’s disease – Treatment Choroid melanoma – Basic Information Prader-Willi syndrome – Basic Information Hereditary motor and sensory neuropathy Atypical teratoid/rhabdoid tumour of CNS – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CHLOROQUINE PHOSPHATE NAVENIBART Sodium Gluconate Estriol Ibuprofen Sodium Dihydrate Cholesterol Elasomeran Heparin SAT-3247 OXALATE ANHYDROUS CALCIUM FOLINATE Methoxyflurane Azetukalner Fludrocortisone Acetate Tilmanocept TIFCEMALIMAB Kyv-101 SOFTISAN 378 Protrans Eftilagimod Alfa Corticosteroids, Plain More therapies…

    Learn about Your Condition

    Brain stem glioma Graves' disease Diverticulitis Castleman's disease Fibrous dysplasia of bone Leiomyosarcoma metastatic Skin bacterial infection Red blood cell abnormality Post procedural complication Radius fracture Epstein-Barr virus infection Psoriasis Thymoma Hyperhidrosis Juvenile absence epilepsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Frisius

Frisius

Henri Dunantweg 2, Heerenveen, 8934 AD, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to liver
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Floxuridine
    • Heparin
    • Bevacizumab
    The Netherlands

  • Study on Personalized Antithrombotic Therapy with Acenocoumarol, Phenprocoumon, and Apixaban for Patients with Aortic Valve Stenosis Post-TAVI

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • Acenocoumarol
    • Phenprocoumon
    • Prasugrel
    Belgium Denmark France Germany The Netherlands

  • Study on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin
    • Venetoclax
    Austria Belgium Estonia Finland Germany Lithuania +2

  • Study on Venetoclax and Epcoritamab for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Epcoritamab
    • Venetoclax
    Belgium Denmark Germany The Netherlands

  • Study of drug combination (capecitabine, fluorouracil, oxaliplatin, calcium folinate) to prevent cancer recurrence in patients with detectable ctDNA after rectal cancer surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    The Netherlands

  • Study on Docetaxel, Cabazitaxel, and Darolutamide for Men with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Cabazitaxel
    • Darolutamide
    • Docetaxel
    The Netherlands

  • Study of Dapansutrile and Paracetamol for Patients with Acute Gout Flare

    Recruiting

    4 1 1
    Investigated Drugs:
    • Dapansutrile
    • Paracetamol
    France The Netherlands Spain

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Phase 3 Study of Etripamil Nasal Spray Compared with Placebo in Patients with Atrial Fibrillation and Rapid Ventricular Rate

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Etripamil
    The Netherlands

  • A study to evaluate the effect of survodutide on protein levels in the urine for patients with chronic kidney disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Germany The Netherlands Spain
Previous Page
1 … 3 4 5 6 7 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!